The present disclosure relates to antibodies specific tumor associated complex N-glycans with terminal GlcNAcβ residues and methods for detecting a tumor in a subject. The present disclosure also relates to therapeutic antibodies specific for tumor associated complex N-glycans with terminal GlcNAcβ residues.